Zell Being

X-ZELL is an award-winning medical technology company specializing in next-generation cytology for early cancer detection. Headquartered in Singapore with operations in Germany and Thailand, the company has developed a proprietary platform that fuses multi-channel immunostaining with digital single-cell imaging and artificial intelligence. Their core technology, including the patented X-ZELL Cryoimmunostaining™, enables the detection and digitization of rare atypical cells (such as tCECs) from minimally invasive 10mL blood samples. X-ZELL's solutions aim to provide same-day, accurate cancer diagnoses that slot seamlessly into existing clinical laboratory workflows, making high-detail diagnostics accessible and scalable globally.